-
US drugmaker closes shop: 'Now we wait for worsened shortages'
A Gurnee, Ill.-based drugmaker is shuttering all U.S. operations, the company told its hundreds of employees during a Feb. 22 Zoom meeting. -
10 systems seeking pharmacy leaders
The following 10 hospitals, health systems and hospital operators have posted job listings seeking pharmacy leaders in the last week. -
CMS copies Aduhelm coverage plan for newly approved Alzheimer's drug
CMS said Feb. 22 it "is not reconsidering" its coverage plan for Alzheimer's drugs that target amyloids — meaning its Aduhelm-era decision will stay true for Leqembi. -
Minnesota's new drug price dashboard shows 42% cost increase over last 5 years
Prescription drug prices in Minnesota have risen nearly 42 percent since 2017, according to a new drug price transparency dashboard recently developed by the Minnesota Department of Health. -
Drugmakers postpone lidocaine resupply dates
Several drugmakers are postponing their lidocaine resupply dates, according to the American Society of Health-System Pharmacists. -
CIDRAP unveils road map to next-generation COVID-19 vaccines: 3 notes
The University of Minnesota's Center for Infectious Disease Research and Policy in Minneapolis published a road map to guide the development of COVID-19 vaccines that offer broad protection against emerging variants and other coronaviruses that may pose a threat in the future. -
FDA may greenlight Pfizer's RSV shot by summer
The FDA will decide whether to approve Pfizer's vaccine candidate for respiratory syncytial virus in August. The shot is administered to expectant mothers and protects infants from severe disease through their first six months of life, the drugmaker said in a Feb. 21 news release. -
Mark Cuban's drug company partners with diabetes management platform
Mark Cuban Cost Plus Drug Co. is teaming up with Diathrive Health to improve healthcare access and lower associated costs for individuals living with diabetes, according to a Feb. 20 announcement. -
HCA pharmacy to consolidate as concerns mount
The Mission Cancer Center Pharmacy in Asheville, N.C., is set to close March 3, and services will be consolidated into the main hospital's pharmacy. -
The future hospital pharmacy technician
As pharmacists step into more roles, pharmacy technicians are also widening their professional strides, experts told Becker's. -
Rite Aid pharmacist allegedly denied immunocompromised patient a COVID-19 shot
In a viral tweet, an Idaho resident accused a Rite Aid pharmacist of canceling his COVID-19 vaccination appointment. -
Michigan cancer center gets approval for oral cancer drug reuse program
The Cancer & Hematology Centers of Western Michigan launched an oral cancer drugs donation and reuse program to reduce medication waste and provide care to low-income patients, ABC affiliate WZZM reported Feb. 20. -
Vanderbilt chooses its chief pharmacy officer
Vanderbilt University Medical Center tapped Mark Sullivan, PharmD, as its chief pharmacy officer Feb. 17. -
Mark Cuban's low-cost pharmacy to partner with independent pharmacists
Mark Cuban Cost Plus Drug Co. announced that it is working on a new program to partner with independent pharmacists in an effort to increase access and affordability of prescription drugs. -
Cuban's pharmacy isn't always the cheapest, but cost isn't the focus, CEO says
As Mark Cuban works to "just f— up the pharmaceutical industry so bad that they bleed," his online pharmacy, Mark Cuban Cost Plus Drug Co., does not always offer the lowest prices. Individual generics aren't the main goal, though, Kaiser Health News reported Feb. 17. -
Pharmacy group praises 2 bills aimed at 'sneaky' PBMs
The National Community Pharmacists Association hailed the Senate Judiciary Committee for its decision to greenlight two bills targeting pharmacy benefit managers. -
Antibiotics tied to rare, serious drug-related skin reactions: Study
Antibiotic use has been linked to two rare but painful and sometimes deadly skin reactions: Stevens-Johnson syndrome and toxic epidermal necrolysis, a new study reports. -
Harvard, Brigham and Women's identify potential targets for new antibiotics
Research from scientists at Harvard Medical School and Brigham and Women's Hospital, both in Boston, have uncovered two families of proteins that may pave the way for the development of new antibiotics in the future. -
Thousands can't access a vital cancer drug treatment
The bladder cancer drug Bacillus Calmette-Guerin is in shortage, forcing thousands of patients to receive rationed treatments instead of a full regimen, CNN reported Feb. 15. -
Report: Heartburn drug's cancer risks were kept quiet for decades
Ranitidine, a heartburn medication sold under the brand name Zantac, was removed from shelves in 2020 after the FDA found a contaminant in it known to cause cancer.
Page 50 of 50